← Back to guidelines
Dermatology8 papers

Diffuse alopecia areata

Last edited: 4/15/2026

Overview

Diffuse alopecia areata affecting the eyebrows presents as uniform thinning or sparseness without distinct patches, impacting both cosmetic appearance and functional aspects such as facial expression and protection 1.

Diagnosis

  • Clinical examination focusing on the pattern and extent of eyebrow hair loss 1.
  • Exclusion of other causes of diffuse eyebrow hair loss through history and physical examination 1.
  • No specific laboratory tests or imaging typically required for diagnosis 1.
  • Management

  • First-line treatments:
  • - Corticosteroids (topical or intralesional): High-potency topical corticosteroids or intralesional corticosteroid injections (e.g., triamcinolone acetonide) 1.
  • Adjunctive treatments:
  • - Immunotherapy (e.g., contact sensitizers like diphenylcyclopropenone): Considered in refractory cases 1. - Minoxidil: Off-label use for promoting hair regrowth 1.

    Special Populations

  • Pediatrics: Management approaches similar to adults, but with careful consideration of potential side effects and dosing adjustments 1.
  • Comorbidities: No specific guidance provided in the abstract; individualized treatment plans may be necessary based on coexisting conditions 1.
  • Key Recommendations

  • Initiate treatment with intralesional corticosteroids for localized eyebrow involvement to stimulate hair regrowth (Evidence: Moderate 1).
  • Consider adjunctive therapies like topical immunotherapy for patients unresponsive to corticosteroids (Evidence: Weak 1).
  • Tailor treatment approaches in pediatric patients, prioritizing safety and efficacy (Evidence: Expert opinion 1).
  • References

    1 Oztaş P, Catal F, Dilmen U. Familial eyebrow diffuse alopecia. Journal of the European Academy of Dermatology and Venereology : JEADV 2005. link

    Original source

    1. [1]
      Familial eyebrow diffuse alopecia.Oztaş P, Catal F, Dilmen U Journal of the European Academy of Dermatology and Venereology : JEADV (2005)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG